BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15599280)

  • 41. Loss of gene expression in lentivirus- and retrovirus-transduced neural progenitor cells is correlated to migration and differentiation in the adult spinal cord.
    Vroemen M; Weidner N; Blesch A
    Exp Neurol; 2005 Sep; 195(1):127-39. PubMed ID: 15921683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenoviral nerve growth factor and beta-galactosidase transfer to spinal cord: a behavioral and histological analysis.
    Boulis NM; Bhatia V; Brindle TI; Holman HT; Krauss DJ; Blaivas M; Hoff JT
    J Neurosurg; 1999 Jan; 90(1 Suppl):99-108. PubMed ID: 10413133
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transplantation of glial progenitors that overexpress glutamate transporter GLT1 preserves diaphragm function following cervical SCI.
    Li K; Javed E; Hala TJ; Sannie D; Regan KA; Maragakis NJ; Wright MC; Poulsen DJ; Lepore AC
    Mol Ther; 2015 Mar; 23(3):533-48. PubMed ID: 25492561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Delivery of GDNF by an E1,E3/E4 deleted adenoviral vector and driven by a GFAP promoter prevents dopaminergic neuron degeneration in a rat model of Parkinson's disease.
    Do Thi NA; Saillour P; Ferrero L; Dedieu JF; Mallet J; Paunio T
    Gene Ther; 2004 May; 11(9):746-56. PubMed ID: 14724667
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adeno-associated viral vector gene expression in the adult rat spinal cord following remote vector delivery.
    Boulis NM; Noordmans AJ; Song DK; Imperiale MJ; Rubin A; Leone P; During M; Feldman EL
    Neurobiol Dis; 2003 Dec; 14(3):535-41. PubMed ID: 14678769
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of transduction efficiency of recombinant AAV serotypes 1, 2, 5, and 8 in the rat nigrostriatal system.
    McFarland NR; Lee JS; Hyman BT; McLean PJ
    J Neurochem; 2009 May; 109(3):838-45. PubMed ID: 19250335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of adenoviral gene expression in spinal cord after remote vector delivery.
    Boulis NM; Turner DE; Dice JA; Bhatia V; Feldman EL
    Neurosurgery; 1999 Jul; 45(1):131-7; discussion 137-8. PubMed ID: 10414575
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Targeting adenoviral transgene expression to neurons.
    Sims K; Ahmed Z; Gonzalez AM; Read ML; Cooper-Charles L; Berry M; Logan A
    Mol Cell Neurosci; 2008 Nov; 39(3):411-7. PubMed ID: 18722531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The feasibility of adenoviral co-transduction of BMP2 and BMP7 for the expression of recombinant human BMP2/7 heterodimer in rat bone marrow mesenchymal stem cells].
    Gao T; Tang S; Niu C; Miao C; Zhang W; Zhou L; Wu C; Liu F
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2016 Mar; 32(2):125-29. PubMed ID: 30024692
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adenovirus vector‑mediated in vivo gene transfer of nuclear factor erythroid‑2p45‑related factor 2 promotes functional recovery following spinal cord contusion.
    Zhu FC; Jiang DM; Zhang MH; Zhao B; He C; Yang J
    Mol Med Rep; 2019 Nov; 20(5):4285-4292. PubMed ID: 31545436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel adenoviral vector which mediates hypoxia-inducible gene expression selectively in neurons.
    Huang D; Desbois A; Hou ST
    Gene Ther; 2005 Sep; 12(18):1369-76. PubMed ID: 15843806
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficient transduction of neurons using Ross River glycoprotein-pseudotyped lentiviral vectors.
    Jakobsson J; Nielsen TT; Staflin K; Georgievska B; Lundberg C
    Gene Ther; 2006 Jun; 13(12):966-73. PubMed ID: 16511527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
    Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
    J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term transgene expression can be mediated in the brain by adenoviral vectors when powerful neuron-specific promoters are used.
    Glover CP; Bienemann AS; Hopton M; Harding TC; Kew JN; Uney JB
    J Gene Med; 2003 Jul; 5(7):554-9. PubMed ID: 12825194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combined Method of Neuronal Cell-Inducible Vector and Valproic Acid for Enhanced Gene Expression under Hypoxic Conditions.
    Yun Y; Baek D; Lee D; Cheong E; Kim J; Oh J; Ha Y
    Tissue Eng Regen Med; 2020 Feb; 17(1):55-66. PubMed ID: 32002843
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Connexin43 and astrocytic gap junctions in the rat spinal cord after acute compression injury.
    Theriault E; Frankenstein UN; Hertzberg EL; Nagy JI
    J Comp Neurol; 1997 Jun; 382(2):199-214. PubMed ID: 9183689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Down-regulation of glial fibrillary acidic protein and vimentin by RNA interference improves acute urinary dysfunction associated with spinal cord injury in rats.
    Toyooka T; Nawashiro H; Shinomiya N; Shima K
    J Neurotrauma; 2011 Apr; 28(4):607-18. PubMed ID: 21250919
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo adenovirus-mediated gene transfer and expression in ischemic rabbit spinal cord.
    Sakurai M; Abe K; Hayashi T; Warita H; Setoguchi Y; Itoyama Y; Tabayashi K
    J Vasc Surg; 1999 Sep; 30(3):542-50. PubMed ID: 10477648
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spinal nociceptive circuit analysis with recombinant adeno-associated viruses: the impact of serotypes and promoters.
    Haenraets K; Foster E; Johannssen H; Kandra V; Frezel N; Steffen T; Jaramillo V; Paterna JC; Zeilhofer HU; Wildner H
    J Neurochem; 2017 Sep; 142(5):721-733. PubMed ID: 28700081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.
    Morelli AE; Larregina AT; Smith-Arica J; Dewey RA; Southgate TD; Ambar B; Fontana A; Castro MG; Lowenstein PR
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():571-583. PubMed ID: 10091995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.